CCS is rapidly establishing itself as a catalyst for connecting innovators, companies, academics, investors, and governmental agencies. With that mission in mind, CCS has formed a partnership with the GlassWall Syndicate (GWS). GWS is a large group of venture capitalists, individual investors, foundations, and trusts to establish a collaborative venue to bring together investors interested in human-specific testing methods with the companies creating these methods.
Click on the connection above to learn more about how your business can interact with investors.
- The company must be working on a technology or product that will replace the use of animals in experimentation.
- The company must be willing to take $25K as a minimum check size from individual investors.